Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-11-07

Clinical Trial Update: Minocycline Hydrochloride in Reducing Chemotherapy-Induced Peripheral Neuropathy and Acute Pain in Patients With Breast Cancer Undergoing Treatment With Paclitaxel [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating minocycline hydrochloride to reduce chemotherapy-induced peripheral neuropathy and acute pain in breast cancer patients treated with pa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Minocycline hydrochloride (minocycline hydrochloride)

Snippet

Sponsor: Academic and Community Cancer Research United | Conditions: Acute Pain, Breast Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2018-11-07